ABSTRACT
Objective The aims of this study were to describe the impact of patient engagement on the initial design and content of a mobile health (mHealth) technology that supports enhanced recovery protocols (ERPs) for cardiac surgery.
Methods Engagement occurred at the level of consultation and took the form of an advisory panel. Patients that underwent cardiac surgery (2017-2018) at St. Boniface Hospital (Winnipeg, Manitoba) and consented to be contacted about future research, and their caregivers, were approached for participation. A qualitative exploration was undertaken to determine advisory panel members’ key messages about, and the impact of, patient engagement on mHealth technology design and content.
Results Ten individuals participated in the advisory panel. Key design-specific messages centered around access, tracking, synchronization, and reminders. Key content-specific messages centered around roles of cardiac surgery team members and medical terms, educational videos, information regarding cardiac surgery procedures, travel before/after surgery, nutrition (i.e., what to eat), medications (i.e., drug interactions), resources (i.e., medical devices), and physical activity (i.e., addressing fears and providing information, recommendations, and instructions). These key messages were a rich source of information for mHealth technology developers and were incorporated as supported by the existing capabilities of the underlying technology platform.
Conclusions Patient engagement facilitated the development of a mHealth technology whose design and content were driven by the lived experiences of cardiac surgery patients and caregivers. The result was a detail-oriented and patient-centered mHealth technology that helps to empower and inform patients and their caregivers about the patient journey across the perioperative period of cardiac surgery.
What is already known about this subject?Enhanced recovery protocols (ERPs) have been proposed as a clinical strategy to effectively address complex and multi-system vulnerabilities, like those commonly present in older adults undergoing cardiac surgery. Mobile health (mHealth) technologies have the potential to improve delivery and patient experience with ERPs, but their development in the academic research setting is often limited by a lack of end-user (e.g., i.e., patient and caregiver) involvement.
What does this study add?To our knowledge, this is one of the first studies to engage patients and caregivers in the development of a mHealth technology that supports ERPs for cardiac surgery. This study describes a process for engaging patients and caregivers as “co-producers” of a mHealth technology to support delivery of ERPs during the perioperative period of cardiac surgery. It also demonstrates that engaging patients and caregivers in research, through the formation of an advisory panel, yields a rich source of information to guide the design and content of mHealth technologies in cardiac research.
How might this impact on clinical practice?In an era in which mHealth technologies are being increasingly looked to for the optimization of healthcare delivery, this study underscores the utility of using patient and caregiver voices to drive the development of patient-centered mHealth technologies to support clinical practice.
Competing Interest Statement
Mses. Dave, Hyra and Ragheb; Mr. Kent; and Drs. Chudyk, Duhamel, and Schultz have no competing interests to disclose. Dr. Arora reports grants from Pfizer Canada Inc., as well as other (i.e., honoraria) from Mallinckrodt Pharmaceuticals, Abbott Nutrition, and Edwards Lifesciences, outside the submitted work. None of the Authors have any formal relationship (financial or non-financial) with the industry partner in this study.
Clinical Trial
The study was not eligible for registration with a clinical trial registry as it is not a clinical trial.
Funding Statement
This work was supported by a GFT research grant from the Department of Surgery (University of Manitoba). Funding for the development of the studys mHealth technology included in-kind contributions from BeeWell Health. The Authors had full control over the data and the company has not seen a version of this publication prior to submission. Dr. Chudyks postdoctoral fellowship was supported by the Department of Family Medicine (University of Manitoba).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Manitoba Research Ethics Board (H2018:458) and the St. Boniface Hospital Research Review Committee Research Ethics Board (RRC/2018/1813).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No data available as advisory panel members were not made aware beforehand that recordings of meeting proceedings would be publicly available.
ABBREVIATIONS
- CABG
- Coronary artery bypass grafting
- CIHR
- Canadian Institutes of Health Research
- ERPs
- Enhanced recovery protocols
- GRIPP2
- Guidance for Reporting Involvement of Patients and the Public
- mHealth
- Mobile health